̽��ֱ��

̽��ֱ��path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.

̽��ֱ�� of Cambridge researchers have developed a novel strategy to tackle neurodegenerative diseases such as Huntington's disease: encouraging an individuals own cells to “eat” the malformed proteins that lead to the disease.